Dec 31, 2018

Cogent Biosciences Q4 2018 Earnings Report

Total Revenue
$3.81M
Previous year: $2.12M
+79.2%
EPS
-$0.29
Previous year: -$1.14
-74.6%
Gross Profit
$3.81M
Previous year: $2.12M
+79.2%
Cash and Equivalents
$55.7M
Free Cash Flow
-$9.02M
Total Assets
$85.9M

Cogent Biosciences

Cogent Biosciences